A carregar...
Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features
Antineoplastic agents that utilize the immune system have revolutionized cancer treatment. Specifically, implementation of immune checkpoint inhibitors, monoclonal antibodies that block cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed death...
Na minha lista:
| Publicado no: | J Am Acad Dermatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492441/ https://ncbi.nlm.nih.gov/pubmed/32360716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.04.105 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|